ZTS stock forecast, quote, news & analysis

Key Takeaways

• Zoetis Inc. (ZTS) stock fell approximately 31% over the past 30 days, driven primarily by disappointing first-quarter 2026 earnings results and a lowered full-year guidance.
• Over the past quarter, the stock declined around 37%, reflecting broader concerns about U.S. companion animal demand softness that intensified after the earnings release.
• The company reported first-quarter revenue of $2.3 billion, up 3% year-over-year but flat on an organic operational basis, missing analyst expectations in key metrics.
• Management reduced 2026 adjusted earnings per share guidance to a range of $6.85 to $7.00, citing weaker U.S. pet spending and competitive pressures.
• Sector and macroeconomic factors, including price sensitivity among pet owners and fewer veterinary visits, amplified negative market sentiment.

Zoetis Inc. (ZTS) Company Overview and Market Position

Zoetis Inc. is the world’s leading animal health company, focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, and diagnostic products for livestock and companion animals. Its core business model centers on providing innovative solutions that improve animal health, productivity, and well-being, serving veterinarians, farmers, and pet owners globally. The company operates in the animal health industry, where it holds a strong competitive position through a diversified portfolio spanning companion animal (pets) and livestock segments, with significant exposure to the U.S. market. These fundamentals help explain recent stock behavior, as softness in U.S. companion animal demand directly pressured results and investor confidence.

Zoetis Inc. (ZTS) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, Zoetis Inc. (ZTS) stock declined approximately 31%, moving from a closing price near $117.52 to $81.32. The movement was sharply negative and event-driven rather than gradual, with most of the decline occurring in a single session following earnings. The stock traded in a relatively narrow range before the catalyst but experienced high volatility afterward.

Over the last quarter, the stock fell approximately 37%, declining from levels near $128.78 to the recent close of $81.32. Performance was range-bound early in the period before the steep drop, reflecting sustained pressures that culminated in the earnings disappointment.

What Drove ZTS Stock Price in the Last 30 Days

The primary catalyst was Zoetis Inc.’s first-quarter 2026 earnings release on May 7, 2026. The company reported adjusted diluted earnings per share of $1.53, missing consensus estimates, and revenue of $2.3 billion that fell short of expectations on an organic operational basis. Management lowered full-year 2026 guidance, projecting adjusted earnings per share between $6.85 and $7.00 and citing softer U.S. pet demand, higher price sensitivity, and reduced veterinary visits. This led to an immediate sharp sell-off, with shares dropping over 20% on the day and continuing lower amid ongoing concerns. Analyst commentary highlighted that the quarter appeared “worse than it seems” due to persistent macro and competitive dynamics in the companion animal segment.

What Drove ZTS Stock Performance Over the Last Quarter

Broader weakness in U.S. companion animal spending weighed on Zoetis Inc. (ZTS) throughout the quarter, with international segments showing relatively stronger growth. Macroeconomic conditions, including inflation-driven caution among pet owners and competitive pressures in the animal health space, created a challenging environment. Institutional investor sentiment shifted negatively as early signs of demand softness emerged, culminating in the guidance cut that confirmed these trends. The cumulative impact of these factors produced the sustained downward trajectory observed over the three-month period.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots from hundreds available on the platform. These bots trade thousands of tickers using varied strategies, timeframes, and performance metrics, with only the top and most relevant ones featured in this section. The neutral presentation allows investors to explore automated trading options aligned with different market approaches. Visit the page to review current trending bots and their details.

ZTS Stock Forecast Drivers: What Investors Should Watch Next

Investors should monitor upcoming quarterly earnings releases for updates on revenue trends and guidance revisions. Key factors include U.S. companion animal demand indicators, such as veterinary visit volumes and pet owner spending patterns. Broader macroeconomic conditions, including inflation and consumer confidence, along with competitive developments in the animal health sector, will remain important. Strategic initiatives, such as new product launches or portfolio adjustments, could also influence sentiment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations